Seres Therapeutics: Q3 Earnings Snapshot
In this article:
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Seres Therapeutics Inc. (MCRB) on Thursday reported a loss of $47.9 million in its third quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 37 cents.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 47 cents per share.
The drug developer posted revenue of $310,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MCRB at https://www.zacks.com/ap/MCRB
